U.S. House · 118th Congress · H.R. 1375
EFFECTIVE Act
To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- David J. TroneD-MD-6
- Introduced
- March 3, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (5)
4 Democrats, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Daniel MeuserR-PA-9
Signed on later
- Ann M. KusterD-NH-2March 23, 2023
- Daniel T. KildeeD-MI-8March 27, 2023
- Josh HarderD-CA-9April 13, 2023
- Brittany PettersenD-CO-7June 20, 2023